A2524712
Cytosine β-<SC>D</SC>-arabinofuranoside hydrochloride , ≥99% , 69-74-9
Synonym(s):
Cytarabine;Arabinosylcytosine;Ara-C;Cytarabine hydrochloride;Cytosine arabinoside
CAS NO.:69-74-9
Empirical Formula: C9H14ClN3O5
Molecular Weight: 279.68
MDL number: MFCD00012839
EINECS: 200-713-9
Pack Size | Price | Stock | Quantity |
250MG | RMB23.20 | In Stock |
|
1G | RMB63.20 | In Stock |
|
5G | RMB218.40 | In Stock |
|
25G | RMB559.20 | In Stock |
|
100g | RMB1759.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 197-198 °C(lit.) |
storage temp. | 2-8°C |
solubility | insoluble in EtOH; ≥14.2 mg/mL in DMSO; ≥64.2 mg/mL in H2O |
form | crystalline |
color | White to off-white |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
InChIKey | KCURWTAZOZXKSJ-XKIMMOKZSA-N |
Description and Uses
Cytosine beta-D-arabinofuranoside Hydrochloride is the salt form of Cytarabine, which is a selective inhibitor of DNA synthesis and is used as an antineoplastic and antiviral. Cytosine beta-D-arabinofuranoside Hydrochloride is used in chemotherapy for the treatment of white blood cells cancers such as acute myeloid leukemia (AML) and non-Hodgkin lymphoma.
Antiviral.
Safety
Symbol(GHS) | GHS07,GHS08 |
Signal word | Warning |
Hazard statements | H317-H319-H341-H361 |
Precautionary statements | P201-P280-P302+P352-P305+P351+P338-P308+P313 |
Hazard Codes | Xn |
Risk Statements | 36-43-63 |
Safety Statements | 26-36/37 |
WGK Germany | 3 |
RTECS | HA5500000 |
HazardClass | IRRITANT |
HS Code | 29389090 |
Toxicity | LD50 oral in rat: > 3200mg/kg |